Ningxing Securities' research report pointed out that Aier Eye Hospital Group (300015.SZ) had steady third quarter revenue, with pressure on gross margin. Q3 gross margin, net margin attributable to mother, non-net margin attributable to mother were 53.9%, 24.4%, 23.1% respectively. According to the interim report, surgery volume growth is faster than revenue growth, while unit price is under pressure. The company's overseas growth rate is significantly faster than domestic, with revenue growth in Europe up by 16.41%, mainly due to the company's acquisition of 100% equity of the UK Optimax Group through the European Clínica Baviera in the first half of the year, while the domestic industry growth is temporarily restricted. It is believed that with the recovery of the macroeconomic environment in the future, the company's domestic business will significantly benefit. The macroeconomic environment change is the core factor putting pressure on the company's business. As a leading private eye hospital, the company's operation is resilient, and its performance has considerable elasticity; first coverage, with a "shareholding" rating.